topiramate treatment with haloperidol in chronic tic disorder

Phase 2

• Conditions: F95.1; chronic tic disorder.; Chronic motor or vocal tic disorder

• Registration Number: IRCT20230803059021N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

parental informed consent
DSM-V criteria for chronic tic disorder
age between 6 and 12

Exclusion Criteria

Presence of major medical disorders such as epilepsy, diabetes, heart and kidney diseases
mental retardation
Hypersensitivity to topiramate and haloperidol
The presence of concomitant psychiatric disorders that require drug intervention
History of long QT syndrome, cardiac arrhythmia, kidney stones and concurrent use of carbonic anhydrase inhibitor drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified